GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity

Adoptive T-cell therapy (ACT) is an emerging paradigm in which T cells are genetically modified to target cancer-associated antigens and eradicate tumors. However, challenges treating epithelial cancers with ACT reflect antigen targets that are not tumor-specific, permitting immune damage to normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Magee, Michael S., Kraft, Crystal L., Abraham, Tara S., Baybutt, Trevor R., Marszalowicz, Glen P., Li, Peng, Waldman, Scott A., Snook, Adam E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087292/
https://www.ncbi.nlm.nih.gov/pubmed/27853651
http://dx.doi.org/10.1080/2162402X.2016.1227897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087292/
https://www.ncbi.nlm.nih.gov/pubmed/27853651
http://dx.doi.org/10.1080/2162402X.2016.1227897

Ejemplares similares